A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
M.D. Anderson Cancer Center
University of Alabama at Birmingham
University of Miami
City of Hope Medical Center
Children's Hospital Medical Center, Cincinnati
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Brown University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Nantes University Hospital
M.D. Anderson Cancer Center
Institut Claudius Regaud
University of Arizona
University of Iowa
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Alabama at Birmingham
University of Alabama at Birmingham
Affiliated Hospital of Qinghai University
Massachusetts General Hospital
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Assiut University
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
University Hospital, Bordeaux
University of Nebraska
Northwestern University
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
UNC Lineberger Comprehensive Cancer Center
Assistance Publique - Hôpitaux de Paris
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
University of Virginia
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Florida
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Ann & Robert H Lurie Children's Hospital of Chicago